Starting Leucovorin for Methotrexate Usage
For low-dose methotrexate (used in rheumatologic and dermatologic conditions), prescribe folic acid supplementation at a minimum of 5 mg per week, NOT leucovorin rescue. Leucovorin rescue is reserved exclusively for high-dose methotrexate regimens (≥500 mg/m² to 15 g/m²) used in oncology settings.
Context: Two Completely Different Scenarios
The term "leucovorin for methotrexate" requires immediate clarification because the approach differs dramatically based on methotrexate dosing:
Low-Dose Methotrexate (Rheumatology/Dermatology)
Use folic acid supplementation, not leucovorin rescue:
- Dose: At least 5 mg folic acid per week 1
- Timing: Given on days when methotrexate is NOT taken 2
- Rationale: Reduces gastrointestinal and hepatic toxicity without compromising efficacy 1
- Grade A recommendation with level 1a evidence 1
The 2020 AAD-NPF guidelines confirm folic acid (not folinic acid/leucovorin) is recommended for psoriasis patients, typically given daily except on methotrexate dosing days 2. The 2009 multinational rheumatology guidelines strongly recommend at least 5 mg weekly, noting that higher doses may be needed with higher methotrexate doses 1.
Critical distinction: Folinic acid (leucovorin) at doses >5 mg/week was associated with reduced methotrexate efficacy in rheumatoid arthritis, showing increased tender and swollen joints 1. Therefore, standard folic acid supplementation is preferred over leucovorin in low-dose settings.
High-Dose Methotrexate (Oncology)
Use leucovorin rescue protocol:
Standard rescue regimen (for methotrexate 12-15 g/m²) 3:
- Dose: 15 mg (approximately 10 mg/m²)
- Timing: Start 24 hours after beginning methotrexate infusion
- Frequency: Every 6 hours for 10 doses (60 hours total)
- Route: PO, IM, or IV (use parenteral if GI toxicity present)
Monitoring requirements 3:
- Serum creatinine and methotrexate levels at least daily
- Continue hydration and urinary alkalinization (pH ≥7.0) until methotrexate level <0.05 micromolar
Dose adjustments based on methotrexate elimination:
| Clinical Situation | Methotrexate Level | Leucovorin Adjustment |
|---|---|---|
| Normal elimination | ~10 µM at 24h, 1 µM at 48h, <0.2 µM at 72h | Standard 15 mg q6h × 10 doses |
| Delayed late elimination | >0.2 µM at 72h, >0.05 µM at 96h | Continue 15 mg q6h until <0.05 µM |
| Delayed early elimination or renal injury | ≥50 µM at 24h OR ≥5 µM at 48h OR creatinine doubled | 150 mg IV q3h until <1 µM, then 15 mg q3h until <0.05 µM |
Common Pitfalls and How to Avoid Them
1. Confusing folic acid with leucovorin (folinic acid):
- Low-dose methotrexate: Use folic acid 5 mg/week minimum
- High-dose methotrexate: Use leucovorin rescue protocol
- These are NOT interchangeable in their indications
2. Timing errors in low-dose regimens:
- Give folic acid on non-methotrexate days to avoid reducing efficacy 2
- Never give folic acid on the same day as weekly methotrexate
3. Delayed leucovorin rescue in high-dose regimens:
- Must start within 24 hours of methotrexate infusion 3
- Delays beyond 36-42 hours significantly increase toxicity risk 4, 5
- Research suggests rescue should start no later than 36 hours for methotrexate 5-6 g/m² 4
4. Inadequate leucovorin dosing:
- The 2009 AAD guidelines note that folinic acid (leucovorin) at 10 mg/m² should be used for hematologic toxicity rescue 6
- For severe toxicity with delayed elimination, doses must be escalated to 150 mg IV q3h 3
- Recent evidence suggests 105 mg/m² may be appropriate for methotrexate 5-6 g/m² 4
5. Stopping leucovorin too early:
- Continue until methotrexate level <0.05 micromolar, regardless of initial schedule 3
- If significant clinical toxicity occurs, extend rescue for additional 24 hours (14 doses over 84 hours) 3
6. Using excessive folinic acid in low-dose settings:
- Folinic acid >5 mg/week reduced methotrexate efficacy in RA 1
- Stick to folic acid supplementation for rheumatologic/dermatologic indications
7. Intrathecal administration:
- Never administer leucovorin intrathecally 3 - this is explicitly contraindicated
Algorithm for Decision-Making
Step 1: Determine methotrexate dose category
- Low-dose (≤30 mg/week): Rheumatology/dermatology indication → Use folic acid supplementation
- High-dose (≥500 mg/m² to 15 g/m²): Oncology indication → Use leucovorin rescue
Step 2: For low-dose methotrexate
- Prescribe folic acid ≥5 mg weekly 1
- Instruct patient to take on non-methotrexate days
- Consider 1 mg daily (except methotrexate day) as alternative 6
Step 3: For high-dose methotrexate
- Start leucovorin 15 mg q6h at 24 hours post-infusion 3
- Monitor methotrexate levels and creatinine daily
- Adjust dose based on elimination pattern (see table above)
- Continue until methotrexate <0.05 micromolar
Step 4: Recognize rescue failure
- Methotrexate ≥50 µM at 24h or ≥5 µM at 48h
- Creatinine increase ≥100% at 24h
- Immediately escalate to 150 mg IV q3h 3